VBL Therapeutics Announces Top-Line Data from Phase 3 OVAL Trial of Ofra-Vec in Patients with Platinum-Resistant Ovarian Cancer
– Trial Did Not Meet Statistical Significance on Improvement in Primary Endpoints of Progression Free…
– Trial Did Not Meet Statistical Significance on Improvement in Primary Endpoints of Progression Free…
REDWOOD CITY, Calif., July 19, 2022 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD), a…
SAN DIEGO and TORONTO, July 19, 2022 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (Nasdaq: APTO;…
Penang, Malaysia–(Newsfile Corp. – July 19, 2022) – Duesenberg Technologies Inc. (OTCQB: DUSYF) (the “Company”…
LIVERMORE, Calif.–(BUSINESS WIRE)–McGrath RentCorp (NASDAQ: MGRC) (the “Company”), a diversified business-to-business rental company, today announced…
SOMERSET, N.J.–(BUSINESS WIRE)–$CMPO–CompoSecure, Inc. (Nasdaq: CMPO), a leading provider of premium financial payment cards and…
STI-1558, an oral SARS-CoV-2 main protease inhibitor which can block viral replication, is specifically designed…
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Overall Ratings Based on Risk-Adjusted Returns NEW YORK–(BUSINESS WIRE)–Today, Defiance ETFs, a leading thematic ETF…
Integrated precision medication management platform empowers clinicians with genetic insights intended to reduce polypharmacy errors…
PASADENA, Calif.–(BUSINESS WIRE)–#BHUSA—Binarly Inc., providers of the industry’s first AI-powered firmware protection platform, today announced…
The relationship gives customers purchasing options across the channel and introduces a new procurement model…
Transformational new capital for acquisitions, conversions, refinancing SAN FRANCISCO–(BUSINESS WIRE)–#AffordableHomes–BRIDGE Housing secured a $250M set-aside…
Idorsia will publish its half year financial results 2022 on Tuesday July 26, 2022, at…
KEY FIGURES Revenue in first half of 2022 –Provisional €616.4 million Growth at constant…
Dr. Drew to Raise Awareness of Petros Pharmaceuticals’ Mission in The Men’s Health Category and…
-Double-Blind, Randomized, Placebo-Controlled HOPE-3 Clinical Trial Designed to Enroll approximately 70 Patients- -HOPE-3 Builds on…
Initiates Fourth Cohort at a 650-Microgram Dose with Data Expected in Q4 2022 SOLANA BEACH,…
Verizon Business Customers Now Able to Join SumUp’s Four Million+ Merchant Network BASKING RIDGE, N.J.,…
NS1 brings critical technology for edge reliability and performance in collaboration with leading innovators NS1’s…